Form 4 Tracker
Arcutis Biotherapeutics, Inc.
ARQT

45 insider filings · Latest: Sep 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 28, 2025May 28 7:47 PMMatsuda Masaru
Proposed Sale
1,800$13.78$24.8K—

View →

May 19, 2025May 19 7:54 PMEdwards Larry Todd
Proposed Sale
7,451$14.07$104.8K—

View →

May 8, 2025May 8 6:54 PMBurnett Patrick
Proposed Sale
3,871$13.59$52.6K—

View →

May 2, 2025May 2 8:24 PMWatanabe Todd Franklin
Proposed Sale
11,448$15.19$173.9K—

View →

May 2, 2025May 2 8:20 PMBurnett Patrick
Proposed Sale
2,597$15.19$39.4K—

View →

May 2, 2025May 2 8:20 PMMatsuda Masaru
Proposed Sale
5,030$15.20$76.5K—

View →

May 1, 2025May 1 8:21 PMWelgus Howard G.
Proposed Sale
10,000$14.64$146.4K—

View →

Apr 2, 2025Apr 2 8:18 PMTopper David Joseph
Proposed Sale
9,600$15.80$151.7K—

View →

Apr 1, 2025Apr 1 8:07 PMWelgus Howard G.
Proposed Sale
10,000$15.12$151.2K—

View →

Mar 25, 2025Mar 25 9:09 PMWatanabe Todd Franklin
Proposed Sale
2,171$17.56$38.1K—

View →

Mar 24, 2025Mar 24 8:20 PMWatanabe Todd Franklin
Proposed Sale
1,500$17.52$26.3K—

View →

Mar 17, 2025Mar 20 9:03 PMWatanabe Todd Franklin
Proposed Sale
1,200$17.61$21.1K—

View →

Mar 4, 2025Mar 14 8:19 PMBurnett Patrick
Proposed Sale
12,242$15.04$184.1K—

View →

Mar 4, 2025Mar 13 9:10 PMBurnett Patrick
Proposed Sale
49,161$14.98$736.4K—

View →

Mar 4, 2025Mar 4 9:47 PMBurnett Patrick
Proposed Sale
954$13.28$12.7K—

View →

Mar 4, 2025Mar 4 9:46 PMWatanabe Todd Franklin
Proposed Sale
4,135$13.28$54.9K—

View →

Mar 3, 2025Mar 3 10:39 PMWatanabe Todd Franklin
Proposed Sale
20,880$13.03$272.1K—

View →

Mar 3, 2025Mar 3 10:38 PMMatsuda Masaru
Proposed Sale
3,263$13.03$42.5K—

View →

Mar 3, 2025Mar 3 10:36 PMBurnett Patrick
Proposed Sale
2,819$13.03$36.7K—

View →

Mar 3, 2025Mar 3 9:50 PMWelgus Howard G.
Proposed Sale
10,000$13.00$130.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Mar 4 1:42 AMMasaru MatsudaReporting Person's title: EVP, Chief Legal Officer
Grant/Award
97,000$26.9797,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMLatha VairavanSVP Chief Financial Officer
Grant/Award
70,000$26.9770,000(D)

View →

Feb 27, 2026Mar 4 1:41 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Grant/Award
77,000$26.9777,000(D)

View →

← Previous

Page 2 of 2